|
31 |
Allogeneic hematopoietic stem cell transplantation for secondary acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT Savani, Bipin N.. - Augsburg : Universität Augsburg, 2016
|
|
|
32 |
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction Pohlen, Michéle Yvonne. - Münster : Universitäts- und Landesbibliothek Münster, 2016
|
|
|
33 |
Patients with acute myeloid leukemia admitted to intensive care units: outcome analysis and risk prediction Pohlen, Michéle Yvonne. - Augsburg : Universität Augsburg, 2016
|
|
|
34 |
18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD) Enthalten in BMC cancer Bd. 21, 10.9.2021, Nr. 1, date:12.2021: 1-10
|
|
|
35 |
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries Enthalten in Leukemia Bd. 38, 6.3.2024, Nr. 4, date:4.2024: 810-821
|
|
|
36 |
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis Enthalten in Annals of hematology Bd. 102, 7.2.2023, Nr. 4, date:4.2023: 755-760
|
|
|
37 |
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients Enthalten in Blood cancer journal Bd. 14, 2.5.2024, Nr. 1, date:12.2024: 1-8
|
|
|
38 |
How risky is a second allogeneic stem cell transplantation? Enthalten in Leukemia Bd. 38, 25.6.2024, Nr. 8, date:8.2024: 1799-1807
|
|
|
39 |
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Enthalten in Journal of hematology & oncology Bd. 15, 5.9.2022, Nr. 1, date:12.2022: 1-15
|
|
|
40 |
Impact of intensified contact precautions while treating hematopoietic stem cell transplantation recipients during aplasia Enthalten in European journal of medical research Bd. 28, 15.3.2023, Nr. 1, date:12.2023: 1-6
|
|